3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Prostatic Neoplasms
2
Lymphoma
2
Sleep Initiation and Maintenance Disorders
1
Sedentary Behavior
1
Oligodendroglioma
1
Meningioma
1
Leukemia, Myeloid, Acute
1
Glioma
1
Glioblastoma
1
Fatigue
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Temozolomide
154
Bevacizumab
88
Radiotherapy
75
Radiation
23
Magnetic Resonance Spectroscopy
23
Lomustine
18
Irinotecan
18
pembrolizumab
17
Surgical Procedures, Operative
16
Carmustine
16
Erlotinib Hydrochloride
12
Nivolumab
11
Specimen Handling
10
Aminolevulinic Acid
10
sargramostim
9
Thalidomide
9
Chemotherapy, Adjuvant
9
Carboplatin
9
Drug Therapy
8
Immunoglobulin G
7
Filgrastim
7
Etoposide
7
Disulfides
7
Cilengitide
7
Sunitinib
6
Sorafenib
6
O(6)-benzylguanine
6
Cyclophosphamide
6
antineoplaston AS 2-1
5
antineoplaston A10
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Glioblastoma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled